Skip to content

Effects of Lactobacillus reuteri and its metabolites on endocrine function and pancreatic immunity following pancreatitis.

Effects of Lactobacillus reuteri and its metabolites on endocrine function and pancreatic immunity following pancreatitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108211
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis, diabetes mellitus

Interventions

Probiotic intervention group:Take oral Lactobacillus reuteri probiotic preparations, 1 capsule each time, once a day, for no less than 10 daysTake oral Lactobacillus reuteri probiotic preparations, 1
Control group:Normal clinical treatment of acute pancreatitis

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute pancreatitis who were hospitalized in the Department of Pancreatic and Biliary Surgery of the First Affiliated Hospital of Harbin Medical University; 2. It is rated as MSAP/SAP based on the improved Marshall scoring system and the revised Atlanta grading system. 3. There has been no recent history of using antibiotics or probiotics, no severe diarrhea, and a regular diet before the onset of the disease.

Exclusion criteria

Exclusion criteria: 1. Chronic pancreatitis; 2. Benign and malignant pancreatic tumors; 3. Allergic constitution: There is an allergy or intolerance to probiotics; 4. Long-term use of antibiotics or immunosuppressants; 5. Those who have been diagnosed with diabetes before the onset of the disease; 6. Pregnant women or those under 18 years old.

Design outcomes

Primary

MeasureTime frame
Endocrine-related indicators;

Secondary

MeasureTime frame
The abundance of Lactobacillus reuteri in the intestine;Immune-related indicators;

Countries

China

Contacts

Public ContactBei Sun

The First Affiliated Hospital of Harbin Medical University

sunbei70@163.com+86 13 603 656 9351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026